3.0.041342024-07-26T08:05:38Z2024-07-26T08:05:38ZHouseHHR2023-06-14118[Congressional Record Volume 169, Number 104 (Wednesday, June 14, 2023)][House]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. SCHIFF:H.R. 4134.Congress has the power to enact this legislation pursuantto the following:Article V of the United States ConstitutionThe single subject of this legislation is:Generic drug labeling[Page H2934]]]>hsif00Energy and Commerce CommitteeHouseStandinghsif14Health SubcommitteeReferred to2023-06-16T18:17:34ZReferred to2023-06-14T14:04:35Z2023-06-16hsif14Health Subcommittee1House committee actionsReferred to the Subcommittee on Health.Committee2023-06-14Referred to the House Committee on Energy and Commerce.IntroReferralH111002House floor actionshsif00Energy and Commerce Committee2023-06-14Introduced in HouseIntroReferralIntro-H9Library of Congress2023-06-14Introduced in HouseIntroReferral10009Library of CongressS001150Rep. Schiff, Adam B. [D-CA-30]ADAMSCHIFFDCAB.30NK000382Rep. Kuster, Ann M. [D-NH-2]AnnKusterDNHM.22023-06-14TrueB001300Rep. Barragan, Nanette Diaz [D-CA-44]NanetteBarraganDCADiaz442023-06-15FalseT000469Rep. Tonko, Paul [D-NY-20]PaulTonkoDNY202024-07-25FalseHealthAdministrative law and regulatory procedures2023-10-30T19:15:51ZDepartment of Health and Human Services2023-10-30T19:15:51ZDrug safety, medical device, and laboratory regulation2023-10-30T19:15:51ZPrescription drugs2023-10-30T19:15:51ZHealth2023-07-19T16:15:20Z002023-06-14Introduced in House2023-10-18T17:46:38ZUpdated Drug Labeling for Patient Safety Act
This bill allows generic drug manufacturers to revise labels with updated safety information that differs from the referenced brand-name drug.
]]>Updated Drug Labeling for Patient Safety ActDisplay Title45Updated Drug Labeling for Patient Safety Act2024-07-24T15:21:31ZShort Title(s) as Introduced101Updated Drug Labeling for Patient Safety Act2024-05-24T13:38:36ZIntroduced in HouseIHOfficial Title as Introduced6To amend the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to establish a process to allow the holders of abbreviated new drug applications to make labeling changes to include new or updated safety-related information, and for other purposes.2024-03-18T21:00:40ZIntroduced in HouseIHIntroduced in House2023-06-14T04:00:00Zhttps://www.govinfo.gov/content/pkg/BILLS-118hr4134ih/xml/BILLS-118hr4134ih.xml2023-06-16Referred to the Subcommittee on Health.text/xmlENPursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.Congressional Research Service, Library of CongressThis file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.